Your browser doesn't support javascript.
loading
Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies.
Sloan, Matthew E; Grant, Caroline W; Gowin, Joshua L; Ramchandani, Vijay A; Le Foll, Bernard.
Afiliação
  • Sloan ME; Section on Human Psychopharmacology, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, 20814, USA.
  • Grant CW; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, 20814, USA.
  • Gowin JL; Section on Human Psychopharmacology, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, 20814, USA.
  • Ramchandani VA; Section on Human Psychopharmacology, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, 20814, USA.
  • Le Foll B; Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, M5S 2S1, Canada. bernard.lefoll@camh.ca.
Acta Pharmacol Sin ; 40(3): 342-350, 2019 Mar.
Article em En | MEDLINE | ID: mdl-30166624

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Receptor CB1 de Canabinoide / Endocanabinoides / Transtornos Mentais Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Receptor CB1 de Canabinoide / Endocanabinoides / Transtornos Mentais Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article